EIF2D (Gene)

Synonyms:EIF2D, ENTREZ:1939, HCA56, HGNC:6583, LGTN, MIM:613709, NM_001201478, NM_006893, NP_001188407, NP_008824, XM_005277509, XM_006711196, XM_011509257, XM_011509258, XM_017000530, XM_017000531, XM_017000532, XP_005277566, XP_006711259, XP_011507559, XP_011507560, XP_016856019, XP_016856020, XP_016856021, XR_001737023, XR_921751, eukaryotic translation initiation factor 2D
Omim:OMIM:613709
Id:ENSG00000143486
Hgnc:HGNC:6583
Entrez:1939
Description:eukaryotic translation initiation factor 2D
This gene encodes a translation initiation factor involved in the recruitment and delivery of aminoacyl-tRNAs to the P-site of the eukaryotic ribosome in a GTP-independent manner. This gene was previously referred to as ligatin, but is now known to localize to the cytoplasm and localize and function with translation factors. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View EIF2D's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with EIF2D.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using EIF2D.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for EIF2D.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with EIF2D.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.